Clinical Trial

Oral, Chemosensory and Trigeminal Functions in Allo-HSCT

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this prospective, cohort study is to learn about smell, taste and trigeminal dysfunction in patients receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT). The research team hypothesizes that treatment with allo-HSCT will induce: * Distortion of taste and smell and trigeminal functions like cooling, tingling, and burning sensations. * Reduced saliva production leading to oral dryness and dental caries. * Changes in the connectivity of the taste-, smell- and pain-cortical brain regions.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-08-21; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT06003660
Lead Sponsor University of Oslo
Conditions Hematopoietic Stem Cell Transplantation
Enrollment 70 participants
Start Date 2023-08-10
Primary Completion 2026-12-30 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-01